About: Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $8.76 (-5.30%)
IMMX NASDAQ Immix Biopharma Inc
Loading watchlist status…
Immix Biopharma Inc share price
IMMX price activity
Last Price
$8.810
Change (24hr)
-0.44 USD (-4.76%)
Volume
762.10K
Volume (4w avg)
-
Open
$9.10
Day Range
$8.81 - $9.10
Previous Close
$9.25
Last Trade
13 Oct, 4:58 pm GMT+0
Delayed
13 Oct, 4:58 pm GMT+0
IMMX price performance
-9.13%
5D
-27.84%
1M
67.5%
YTD
250.4%
1Y
Delayed
13 Oct, 4:58 pm GMT+0
IMMX Market Signals